HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b

Enzyme immunoassays for quantifying hepatitis C virus (HCV) core antigen (Ag) have been proposed as an alternative to HCV RNA detection. The present study aimed to investigate the early kinetics of serum HCVcAg and its usefulness in predicting virological responses. The clinical data of 135 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhijuan, Liu, Junfeng, Wang, Fengmei, Liu, Jingmin, Ding, Xian, Liu, Shuye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417632/
https://www.ncbi.nlm.nih.gov/pubmed/30855495
http://dx.doi.org/10.1097/MD.0000000000014795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417632/
https://www.ncbi.nlm.nih.gov/pubmed/30855495
http://dx.doi.org/10.1097/MD.0000000000014795

Ejemplares similares